ArticleBriefings in bioinformatics2025
Fusion of spatiotemporal and network models to prioritize multiscale effects in single-cell perturbations.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Artificial intelligence in biomarker discovery for diseases: diagnostic and therapeutic prospects.Signal transduction and targeted therapy · 2026Review
- PICDGI: A framework for predicting cancer driver genes through dynamic gene-gene interaction modeling of single-cell data.PLoS computational biology · 2026Article
- GALA: a unified landmark-free framework for coarse-to-fine spatial alignment across resolutions and modalities in spatial transcriptomics.Briefings in bioinformatics · 2026Article
- CONCERT predicts niche-aware perturbation responses in spatial transcriptomics.bioRxiv : the preprint server for biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Understanding how cells respond to biological perturbations over time and across tissues is key to identifying regulators and networks that inform personalized medicine. Current methods struggle to quantify these dynamic influences in complex multicellular or multitissue systems, especially using single-cell data with spatial and temporal resolution. To address this, we introduce Perturb-STNet, a novel framework that leverages network-based spatiotemporal models to rank spatial and temporal differentially expressed regulators due to perturbation (pSTDERs) driving developmental and disease processes. Perturb-STNet identifies significant pSTDERs, estimates dynamic regulatory networks, and provides detailed visualizations of regulator, cell, and neighborhood interactions critical for understanding disease progression and therapeutic responses. We validated Perturb-STNet using synthetic data and epithelial-to-mesenchymal transition lung cancer data, showing superior performance compared to standard methods. Additionally, we applied it to CODEX single-cell imaging temporal data from a murine melanoma model to study CD8+ T-cell therapy effects, and to MERFISH spatial transcriptomics temporal data to explore inflammation and tissue repair in colitis. In melanoma, Perturb-STNet uncovered regulators like KLRG1 and CD79b, along with mediating pairs and triples (IgD-H2kb, PDL1-H2kb, NKP46-CD117, and FOXP3-CD5-CD25), revealing therapeutic strategies including checkpoint inhibition by targeting PDL1-H2kb to restore CD8+ T cell function, Treg depletion through inhibition of FOXP3-CD5-CD25 axis, and NK cell activation by enhancing NKP46-CD117 interactions. In colitis, Perturb-STNet identified key genes (Csf1r, Col6a1, Lgr4, Myc, and Fzd5) and mediator pairs (Itga5-Flnc, Cd68-Csf1r, Csf1r-Cx3cl1, and Tnfrsf1b-Bmp1) involved in immune regulation, matrix remodeling, and epithelial repair, offering potential therapeutic targets. Overall, Perturb-STNet enables robust identification of spatiotemporal regulatory networks in single-cell perturbation data across diverse disease contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.